FDPs are fragments produced by proteolytic digestion of fibrinogen or fibrin by plasmin. For determination of FDPs, blood is collected in a tube containing thrombin (to remove all fibrinogen by converting it into a clot) and soybean trypsin inhibitor (to inhibit plasmin and thus prevent in vitro breakdown of fibrin). A suspension of latex particles linked to antifibrinogen antibodies (or fragments D and E) is mixed with dilutions of patient’s serum on a glass slide. If FDPs are present, agglutination of latex particles occurs (see Figure 814.1). The highest dilution of serum at which agglutination is detected is used to determine concentration of FDPs. Increased levels of FDPs occur in fibrinogenolysis or fibrinolysis. This occurs in disseminated intravascular coagulation, deep venous thrombosis, severe pneumonia, and recent myocardial infarction.
TEST FOR FIBRINOGEN/FIBRIN DEGRADATION PRODUCTS (FDPs)
By Dayyal Dg. | Medically reviewed by a board-certified member
Published: August 03, 2017 | Updated: August 06, 2017
- Also Read: LABORATORY TESTS IN BLEEDING DISORDERS
Last modified on Sunday, 06 August 2017 07:07
Read 1264 times
Get real-time alerts and all the latest updates on your phone with the BIOSCIENCE mobile app. Download from
Clinical laboratory professional specialized to external quality assessment (proficiency testing) schemes for Laboratory medicine and clinical pathology. Author/Writer/Blogger
Latest from Dayyal Dg.
- Blood Group Systems
- Screening Tests for Infections Transmissible by Transfusion
- Adverse Effects of Transfusion
- Detection of Fake or Adulterate Urine Sample
- 10 Tips to Look After Your Teeth
- Difference Between Warts, Corns and Calluses
- Stool Examination for Ova and Parasites
- Is the protection of mental health a priority taught in your schools?